Sprekers bij Lunch Webinar Discussie 'Why invest in Healthcare Innovations?'

Laura Nelson Carney is an equity investment analyst and research director at Capital Group, with research responsibility for pharmaceutical and biotechnology companies in Europe and Asia. She has nine years of investment industry experience and has been with Capital Group for six years. Prior to joining Capital, Nelson Carney worked as an equity research analyst at Sanford C. Bernstein, covering Asia-Pacific healthcare. Before that, she was a management consultant at McKinsey & Company, a research scientist at Merck and a postdoctoral fellow at Imperial College London. She holds a PhD in neurosciences from Imperial College London and a bachelor's degree in human biology from Stanford University.